A scoping review on laboratory surveillance in the WHO Southeast Asia Region: Past, present and the future
Description
CONCLUSION: Regionally and nationally integrated genomic and laboratory surveillance systems justify capital investments, as their payoffs rationalise such costs owing to economies of scale over time. Further, as data flows are harmonized and
